View in EDS

Janus kinase and calcineurin‐inhibitor combination in anti‐MDA5 dermatomyositis: No significant survival benefit but reassuring safety profile.

Saved in:
Bibliographic Details
Title: Janus kinase and calcineurin‐inhibitor combination in anti‐MDA5 dermatomyositis: No significant survival benefit but reassuring safety profile.
Authors: Pagis, Valentine1 (AUTHOR) valentine.pagis@aphp.fr, Astouati, Quentin2 (AUTHOR), Pacoureau, Lucas3 (AUTHOR), Nguyen, Yann4 (AUTHOR), Bay, Pierre5,6 (AUTHOR), Roux, Antoine7 (AUTHOR), Gallay, Laure8 (AUTHOR), Cottin, Vincent9 (AUTHOR), Terrier, Benjamin10 (AUTHOR), Meyer, Alain11 (AUTHOR), Cerf, Charles12 (AUTHOR), Neuville, Mathilde12 (AUTHOR), Hervier, Baptiste13 (AUTHOR), Renaud, Arthur14 (AUTHOR), Suzon, Benoit15 (AUTHOR), Schleinitz, Nicolas16 (AUTHOR), Papo, Thomas17 (AUTHOR), Priou, Pascaline18 (AUTHOR), Mekinian, Arsène19 (AUTHOR), Ullmer, Audrey20 (AUTHOR)
Source: Journal of Internal Medicine. Feb2026, Vol. 299 Issue 2, p228-240. 13p.
Database: Academic Search Ultimate
Description
ISSN:09546820
DOI:10.1111/joim.70047